蓝帆医疗: 关于预计触发可转债转股价格向下修正条件的提示性公告

Core Viewpoint - The company anticipates triggering the condition for a downward adjustment of the convertible bond conversion price due to the closing price being below 85% of the current conversion price for 10 consecutive trading days [2][8]. Summary by Relevant Sections Convertible Bond Issuance and Listing - The company issued convertible bonds approved by the China Securities Regulatory Commission with a total amount of 314.404 million yuan, with a face value of 100 yuan per bond, and these bonds were listed on June 19, 2020 [2][3]. Conversion Price Adjustment History - The conversion price was adjusted from 17.79 yuan/share to 18.64 yuan/share on June 25, 2021, following the repurchase and cancellation of shares [3]. - Further adjustments were made, reducing the conversion price to 18.24 yuan/share on July 7, 2021, and then to 17.84 yuan/share on May 31, 2023 [4]. - The board proposed a downward adjustment to 12.50 yuan/share effective from May 21, 2024, and subsequently to 12.00 yuan/share effective from July 8, 2025 [5][6]. Conditions for Downward Adjustment - The board has the authority to propose a downward adjustment of the conversion price if the stock price is below 85% of the current conversion price for at least 15 out of 30 consecutive trading days [7]. - The adjusted conversion price must not be lower than the higher of the average stock price over the 20 trading days prior to the shareholders' meeting and the latest audited net asset value per share [7][8]. Upcoming Actions - If the condition for downward adjustment is triggered, the board will convene to decide on the adjustment and disclose the decision the following trading day [8].